Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 27 (9), 1091-7

Prevalence and Distribution of Human Papillomavirus Infection in Korean Women as Determined by Restriction Fragment Mass Polymorphism Assay


Prevalence and Distribution of Human Papillomavirus Infection in Korean Women as Determined by Restriction Fragment Mass Polymorphism Assay

Eun Hee Lee et al. J Korean Med Sci.


The development of a prophylactic vaccine that targets human papillomaviruses (HPV) 6, 11, 16, and 18 to prevent cervical cancer has increased interest in the ethnic and geographical distributions of HPV genotypes. We investigated HPV prevalence and type distribution by restriction fragment mass polymorphism (RFMP) testing a total of 60,775 specimens (aged 18-79 yr, median 44) taken from liquid-based cytology. Overall HPV positive rate of total patients was 34.2%. Among the positive patients, 87.7% was single type infections, and 12.3% was multiple HPV types. HPV-16 was the most prevalent genotype observed in 2,307 (26.0%), followed by type 52 in 2,269 (25.5%), type 58 in 1,090 (12.3%), type 18 in 633 (7.1%), type 56 in 436 (4.9%). The pattern of high risk-HPV positive rate according to age showed U-shape with a peak in HPV prevalence among women less than 30 yr of age, and a second peak among the older females aged 70 to 79 yr. The leading four high-risk HPV genotypes were HPV-16, HPV-52, HPV-58, and HPV-18 in descending order. In conclusion, this study provides the most representative prevalence and type-specific distribution of HPV among Korean women, and demonstrates that the epidemiology of HPV infection is different from that of other regions of the world.

Keywords: Distribution; Genotype; Human Papillomavirus; Korean; Prevalence; RFMP.


Fig. 1
Fig. 1
Overall HPV positive rate and multiple infection rate of HPV positive patients stratified by age.
Fig. 2
Fig. 2
The distribution of high-risk HPV genotypes according to age groups.

Similar articles

See all similar articles

Cited by 16 PubMed Central articles

See all "Cited by" articles


    1. zur Hausen H. Papillomaviruses and cancer from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–350. - PubMed
    1. de Villiers EM, Whitley C, Gunst K. Identification of new papillomavirus types. Methods Mol Med. 2005;119:1–13. - PubMed
    1. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–527. - PubMed
    1. Huang S, Afonina I, Miller BA, Beckmann AM. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer. 1997;70:408–411. - PubMed
    1. Lai HC, Sun CA, Yu MH, Chen HJ, Liu HS, Chu TY. Favorable clinical outcome of cervical cancers infected with human papillomavirus type 58 and related types. Int J Cancer. 1999;84:553–557. - PubMed

Publication types